Quest 10 Wealth Builders’s AstraZeneca AZN Stock Holding History

Quest 10 Wealth Builders’s Portfolio AZN Stock Details AZN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$11.6K	Hold	61	–	–	0.01%	424
2026 Q1	$12K	Sell	61 -1	-2%	-$193	0.01%	418
2025 Q4	$11.3K	Sell	62 -19	-23%	-$3.33K	0.01%	394
2025 Q3	$12.4K	Buy	81 +19	+31%	+$2.88K	0.01%	348
2025 Q2	$8.6K	Hold	62	–	–	0.01%	422
2025 Q1	$9.04K	Hold	62	–	–	0.01%	377
2024 Q4	$8.06K	Buy	+62	New	+$8.68K	0.01%	424

Other funds holding AZN

Evelyn Partners London $46.9B AUM

Investor AB Stockholm, Sweden $14.4B AUM 4.07% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Legal & General Group London, United Kingdom $480B AUM 42.84% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Quest 10 Wealth Builders's AZN Position: Q2 2026 in Review

Quest 10 Wealth Builders held its AstraZeneca (AZN) position steady in Q2 2026 at 61 shares worth $11.6K. The position accounts for 0.01% of the portfolio, ranked #424.

Quest 10 Wealth Builders first reported a position in AZN in Q4 2024 and has held it in 7 quarters since. The position peaked at $12.4K in Q3 2025. 1,502 funds tracked by Wall St. Rank hold AZN as of Q2 2026.

Quest 10 Wealth Builders held 61 shares of AstraZeneca worth $11.6K as of Q2 2026.
Quest 10 Wealth Builders left its AstraZeneca share count unchanged in Q2 2026.
AstraZeneca made up 0.01% of Quest 10 Wealth Builders's portfolio in Q2 2026, its #424 holding.
Quest 10 Wealth Builders first reported a position in AstraZeneca in Q4 2024 and has held it in 7 quarters since.
Quest 10 Wealth Builders's AstraZeneca position peaked at $12.4K in Q3 2025.
1,502 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2026.

Based on Quest 10 Wealth Builders's 13F filing for Q2 2026, filed 24 Jul 2026.